RG2417

· Repligen Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RG2417, covering 2007-11-09 to 2011-01-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression [Phase 2]